Immobilized HLA-G&B2M&Peptide (RIIPRHLQL) Monomer, His & Avi, Rhesus macaque, His Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Rhesus macaque LILRB1, hFc Tag with the EC50 of 2.2 μg/ml determined by ELISA.
The purity of HLA-G&B2M&Peptide (RIIPRHLQL) Monomer, His & Avi, Rhesus macaquer is greater than 95% as determined by SEC-HPLC.
HLA-G&B2M&Peptide (RIIPRHLQL) Monomer, His & Avi, Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Rhesus macaque LILRB1, hFc Tag captured on CM5 Chip via Protein A can bind HLA-G&B2M&Peptide (RIIPRHLQL) Monomer, His & Avi, Rhesus macaque, His Tag with an affinity constant of 27.18 nM as determined in SPR assay (Biacore T200).
HLA-G&B2M&Peptide (RIIPRHLQL) Monomer, His & Avi, Rhesus macaque
HLA-G is a molecule that was first known to confer protection to the fetus from destruction by the immune system of its mother, thus critically contributing to fetal-maternal tolerance. The first functional finding constituted the basis for HLA-G research and can be summarized as such: HLA-G, membrane-bound or soluble, strongly binds its inhibitory receptors on immune cells (NK, T, B, monocytes/dendritic cells), inhibits the functions of these effectors, and so induces immune inhibition.
| Z06678 | |
|
|
|
| ¥63,425.00 | |
|
|
|
|
|
|
| Ask us a question | |
